ChemRar Ventures — Email, Phone & Partners

Overview

ChemRar Ventures is a Russian venture capital firm specializing in investments within the pharmaceutical and biotechnology sectors. The firm is part of the ChemRar Group, a conglomerate that unites research, manufacturing, and investment companies dedicated to the development and commercialization of innovative medicines, diagnostics, and treatments for life-threatening diseases both in Russia and internationally. ChemRar Ventures manages a diversified portfolio of investments in innovative biotechnological and biopharmaceutical companies, aiming to advance healthcare solutions and improve patient outcomes. The firm's investment strategy encompasses various stages of company development, including seed, early stage, Series A, Series B, growth, late stage, and pre-IPO rounds. ChemRar Ventures focuses on a wide geographical area, with investments spanning Russia, the United States, the European Union, China, India, Brazil, Japan, South Korea, Canada, Australia, Mexico, South Africa, Turkey, Saudi Arabia, Argentina, the United Kingdom, France, Germany, Italy, and Spain. This broad geographical focus allows the firm to tap into diverse markets and identify promising opportunities in the global pharmaceutical and biotechnology landscape. ChemRar Ventures has a history of active involvement in the development of antiviral drugs, notably collaborating with the Russian Direct Investment Fund (RDIF) to produce Avifavir, the first favipiravir-based drug approved for the treatment of COVID-19. This partnership underscores the firm's commitment to addressing global health challenges through innovative pharmaceutical solutions. By leveraging its extensive network and expertise, ChemRar Ventures continues to support the growth and success of its portfolio companies, contributing to advancements in medical treatments and therapies worldwide.

Investment Focus

Innovative biotechnological and biopharmaceutical companies
Companies in seed to pre-IPO stages
Companies operating in Russia and internationally

Portfolio Companies

AvironViriomAvineuroCardioSystemPharmaNewVacChromis

Get the full list of 54,000+ investors

ChemRar Ventures and every other firm and angel in the database — as one spreadsheet you keep.

$19one-time payment · no subscription

All 54,000+ investors — VC firms, private equity, family offices and angels
The key person to contact at each one, with their job title
Their work email address
Their phone number
Their LinkedIn profile
Delivered as a single .xlsx file — download it as many times as you like

Get the full list — $19 → One payment. No seats, no credits, no expiry. Already bought it? Sign in to download it again — no second payment.

Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.

Frequently asked questions about ChemRar Ventures

What sectors does ChemRar Ventures invest in?

ChemRar Ventures invests in Technology, Healthcare, Energy, Consumer Goods, Real Estate and Materials, and is based in Moscow Region, Russia. ChemRar Ventures is listed as a venture capital in the ConnectSafely investor database.